Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.700
-0.070 (-1.47%)
Nov 21, 2024, 11:16 AM EST - Market open
Tenax Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 16 | 7 | 5 | 26 | 23 | 10 | |
| Market Cap Growth | 65.31% | 31.60% | -81.01% | 11.69% | 146.95% | 160.44% | |
| Enterprise Value | -82 | -4 | 1 | 18 | 15 | 3 | |
| Last Close Price | 4.77 | 21.97 | 178.24 | 1664.00 | 2976.00 | 2256.00 | |
| PB Ratio | 0.17 | 0.81 | 3.34 | 6.18 | 5.07 | 2.52 | |
| P/TBV Ratio | 0.12 | 0.81 | 3.34 | 6.18 | 5.07 | 2.52 | |
| Debt / Equity Ratio | - | 0.06 | 0.54 | 0.07 | 0.07 | 0.05 | |
| Quick Ratio | 38.38 | 2.73 | 1.15 | 3.57 | 3.17 | 2.13 | |
| Current Ratio | 38.95 | 3.26 | 1.74 | 3.64 | 3.21 | 2.44 | |
| Return on Equity (ROE) | -26.84% | -160.79% | -385.12% | -732.21% | -234.61% | -108.01% | |
| Return on Assets (ROA) | -17.39% | -68.21% | -147.02% | -306.43% | -93.21% | -54.28% | |
| Return on Capital (ROIC) | -17.87% | -94.43% | -202.10% | -416.33% | -138.99% | -68.05% | |
| Earnings Yield | -89.55% | -117.67% | -221.89% | -123.88% | -41.97% | -88.32% | |
| FCF Yield | -90.09% | -228.77% | -41.43% | -39.52% | -79.54% | |
| Buyback Yield / Dilution | -3389.71% | -1250.92% | -43.00% | - | - | - | |
| Total Shareholder Return | -3389.71% | -1250.92% | -43.00% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.